In a significant advancement for regenerative medicine and oncology, a multidisciplinary team of scientists from the University of Basel and…
Read More

In a significant advancement for regenerative medicine and oncology, a multidisciplinary team of scientists from the University of Basel and…
Read More
The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
The Challenge of Estrogen Receptor-Positive Breast Cancer Estrogen receptor-positive (ER+) breast cancer represents approximately 70% to 80% of all breast…
Read More
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, particularly checkpoint inhibitors, offering…
Read More
The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…
Read More
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
The traditional understanding of glioblastoma multiforme (GBM) as a localized malignancy confined within the blood-brain barrier is being fundamentally challenged…
Read More
The field of ovarian cancer research is undergoing a profound transformation, driven by significant advancements in personalized medicine and innovative…
Read More
A Century of Illuminating Science: The Enduring Mission of Science News For over a century, Science News has stood as…
Read More
The Hidden Threat of Estrogen Receptor-Positive Breast Cancer Estrogen receptor-positive (ER+) breast cancer is the most prevalent form of the…
Read More